MX390903B - Composición y método para el crecimiento del cabello. - Google Patents

Composición y método para el crecimiento del cabello.

Info

Publication number
MX390903B
MX390903B MX2021006697A MX2021006697A MX390903B MX 390903 B MX390903 B MX 390903B MX 2021006697 A MX2021006697 A MX 2021006697A MX 2021006697 A MX2021006697 A MX 2021006697A MX 390903 B MX390903 B MX 390903B
Authority
MX
Mexico
Prior art keywords
sub
hair growth
composition
compositions
cellulose
Prior art date
Application number
MX2021006697A
Other languages
English (en)
Spanish (es)
Other versions
MX2021006697A (es
Inventor
Jeffrey M Wu
Original Assignee
Johnson & Johnson Consumer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Consumer Inc filed Critical Johnson & Johnson Consumer Inc
Publication of MX2021006697A publication Critical patent/MX2021006697A/es
Publication of MX390903B publication Critical patent/MX390903B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/362—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/731—Cellulose; Quaternized cellulose derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86—Polyethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/26—Optical properties
    • A61K2800/262—Transparent; Translucent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/48—Thickener, Thickening system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/49—Solubiliser, Solubilising system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures
    • A61K2800/594—Mixtures of polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Detergent Compositions (AREA)
MX2021006697A 2015-12-28 2016-12-22 Composición y método para el crecimiento del cabello. MX390903B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562271405P 2015-12-28 2015-12-28
US15/387,637 US11666520B2 (en) 2015-12-28 2016-12-21 Hair growth composition and method
PCT/US2016/068188 WO2017116938A1 (en) 2015-12-28 2016-12-22 Hair growth composition and method

Publications (2)

Publication Number Publication Date
MX2021006697A MX2021006697A (es) 2022-03-24
MX390903B true MX390903B (es) 2025-03-21

Family

ID=59086054

Family Applications (4)

Application Number Title Priority Date Filing Date
MX2021006697A MX390903B (es) 2015-12-28 2016-12-22 Composición y método para el crecimiento del cabello.
MX2018008012A MX387098B (es) 2015-12-28 2016-12-22 Composicion y metodo para el crecimiento del pelo.
MX2018008010A MX382837B (es) 2015-12-28 2016-12-22 Composición y método para el crecimiento del pelo.
MX2018008011A MX386927B (es) 2015-12-28 2016-12-22 Composicion y metodo para el crecimiento del cabello.

Family Applications After (3)

Application Number Title Priority Date Filing Date
MX2018008012A MX387098B (es) 2015-12-28 2016-12-22 Composicion y metodo para el crecimiento del pelo.
MX2018008010A MX382837B (es) 2015-12-28 2016-12-22 Composición y método para el crecimiento del pelo.
MX2018008011A MX386927B (es) 2015-12-28 2016-12-22 Composicion y metodo para el crecimiento del cabello.

Country Status (15)

Country Link
US (5) US10561593B2 (enExample)
EP (3) EP3397350A1 (enExample)
JP (6) JP7430487B2 (enExample)
KR (3) KR102795824B1 (enExample)
CN (3) CN108472511B (enExample)
AU (6) AU2016381084A1 (enExample)
BR (3) BR112018013174B8 (enExample)
CA (3) CA3006581C (enExample)
ES (1) ES2878189T3 (enExample)
IL (3) IL259696A (enExample)
MX (4) MX390903B (enExample)
RU (3) RU2018127471A (enExample)
TW (3) TWI730023B (enExample)
WO (3) WO2017116938A1 (enExample)
ZA (3) ZA201803518B (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9675537B2 (en) * 2014-06-30 2017-06-13 Johnson & Johnson Consumer Inc. Hair growth composition and method
US10561593B2 (en) 2015-12-28 2020-02-18 Johnson & Johnson Consumer Inc. Hair growth composition and method
CA3110856C (en) 2018-08-26 2024-05-28 Hair Plus Health Llc Methods and compositions to increase hair growth and/or prevent hair loss
GB201817625D0 (en) * 2018-10-29 2018-12-12 Givaudan Sa Hair care active agent
CA3132693A1 (en) 2019-03-08 2020-09-17 Colgate-Palmolive Company Personal care compositions
JP2021021028A (ja) * 2019-07-30 2021-02-18 株式会社カネカ ゴムグラフト共重合体の製造方法
US10987355B2 (en) 2019-08-07 2021-04-27 Aneira Pharma, Inc. Methods and compositions for the treatment of hair loss
KR20220066068A (ko) * 2019-08-21 2022-05-23 팀버 파마슈티칼스, 인코포레이티드 활성 제제의 국소 전달을 위한 용매 전달 시스템
US11331253B2 (en) 2019-11-14 2022-05-17 Colgate-Palmolive Company Personal care compositions for treating odor causing bacteria and methods for the same
JP2021123583A (ja) * 2020-01-31 2021-08-30 大正製薬株式会社 外用医薬製剤
MX2022010979A (es) * 2020-03-09 2022-10-07 Colgate Palmolive Co Composiciones para el cuidado personal.
CN111671772B (zh) * 2020-05-28 2021-04-13 中国农业科学院特产研究所 一种外泌体在制备修复皮肤损伤的药品或化妆品中的应用
CN116615465B (zh) * 2020-11-27 2025-02-25 日本制纸株式会社 含气泡组合物制造用添加剂
WO2022216789A1 (en) * 2021-04-06 2022-10-13 Isp Investments Llc Aqueous personal care compositions comprising carboxymethyl cellulose (cmc) having an optimized degree of substitution
KR20240046752A (ko) * 2021-08-13 2024-04-09 아이에스피 인베스트먼츠 엘엘씨 카르복시메틸 셀룰로스 (cmc)를 포함하는 수성 개인 관리 조성물, 그를 제조하는 방법 및 그의 용도
US12201713B2 (en) * 2021-09-01 2025-01-21 Colgate-Palmolive Company Personal care compositions
CA3229429A1 (en) 2021-09-03 2023-03-09 Colgate-Palmolive Company Personal care compositions
TWI826829B (zh) * 2021-09-27 2023-12-21 芙姵爾生醫股份有限公司 鹿茸萃取物用於毛髮修護與促進毛髮新生之用途
US11744788B2 (en) * 2021-10-27 2023-09-05 James D. Welch Method of encouraging growth and regrowth of hair in human males technical area
CN115381751A (zh) * 2022-10-08 2022-11-25 广州大唐化妆品有限公司 一种控油组合物及其应用
CN115475168B (zh) * 2022-10-18 2024-02-13 湖北工业大学 含米诺地尔的药物组合物及其制备方法和应用
AU2023366929A1 (en) 2022-10-25 2025-05-08 Veradermics, Incorporated Compositions and methods of use for modified release minoxidil
KR20240147009A (ko) 2023-03-30 2024-10-08 신신제약 주식회사 미녹시딜을 함유하는 탈모 치료용 조성물
US20240398802A1 (en) * 2023-06-01 2024-12-05 Noor Brands Company, Llc Topical Compositions and Methods for Hair Growth
CN116688100A (zh) * 2023-07-12 2023-09-05 北京益华生物科技有限公司 一种促进毛囊再生的组合物及制备方法和应用
WO2025160375A1 (en) * 2024-01-25 2025-07-31 Chouwan Prakash Natural hair oil compositions and methods for making such compositions

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4897269A (en) 1984-09-24 1990-01-30 Mezei Associates Limited Administration of drugs with multiphase liposomal delivery system
JPH072628B2 (ja) * 1986-03-31 1995-01-18 日東電工株式会社 養毛組成物
IT1226385B (it) * 1988-07-08 1991-01-15 Enichem Tecnoresine Policarbonati resistenti alla fiamma contenenti unita' derivanti da composti macrociclici alogenati.
US4874794A (en) 1989-04-28 1989-10-17 Lidak Biopharmaceuticals Inflammatory disease treatment
US5658956A (en) 1991-03-01 1997-08-19 Warner-Lambert Company Bioadhesive-wound healing compositions and methods for preparing and using same
GB9109734D0 (en) 1991-05-07 1991-06-26 Unilever Plc Cosmetic composition
US5133967A (en) 1991-06-24 1992-07-28 The Dow Chemical Company Toning composition and process of using
JPH0525025A (ja) 1991-07-22 1993-02-02 Kao Corp 毛髪化粧料
KR940006529B1 (ko) 1992-01-14 1994-07-21 이덕중 자장을 이용한 발모촉진기
GB9210768D0 (en) * 1992-05-20 1992-07-08 Unilever Plc Cosmetic composition
EP0640643B1 (en) 1993-08-10 2000-04-26 Kao Corporation Organopolysiloxanes and a method of setting hair using the same
DE4402527A1 (de) 1994-01-28 1995-08-03 Henkel Kgaa Wäßrige Lösungen von Esterquats
JP4048567B2 (ja) 1994-12-20 2008-02-20 三菱化学株式会社 長鎖カルボン酸乳酸エステル塩水溶液
US5834014A (en) 1995-10-06 1998-11-10 The Regents Of The University Of Michigan Stimulation of hair follicles
JPH10218736A (ja) 1997-02-10 1998-08-18 Taisho Pharmaceut Co Ltd 育毛剤
FR2760636B1 (fr) 1997-03-14 1999-04-30 Oreal Composition gelifiee vaporisable
JPH1192378A (ja) 1997-09-19 1999-04-06 Taisho Pharmaceut Co Ltd 外用育毛液剤
US5972358A (en) * 1998-01-20 1999-10-26 Ethicon, Inc. Low tack lotion, gels and creams
CN1293564A (zh) 1998-03-16 2001-05-02 宝洁公司 调节皮肤外观的方法
AUPP310798A0 (en) * 1998-04-22 1998-05-14 Soltec Research Pty Ltd Vehicle system for a composition comprising a piperidinopyrimidine derivative
US6284234B1 (en) 1998-08-04 2001-09-04 Johnson & Johnson Consumer Companies, Inc. Topical delivery systems for active agents
US20020006418A1 (en) 1998-10-13 2002-01-17 John Kung Composition to enhance permeation of topical skin agents
US20020172693A1 (en) * 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020037914A1 (en) 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US7442369B1 (en) 2000-08-09 2008-10-28 Mcneil Ab Compositions of minoxidil
US7592002B2 (en) * 2005-10-31 2009-09-22 Bioderm Research Sugar esters for depilation (hair removal), demabrasion, and wrinkles reduction
US20040142853A1 (en) * 2002-11-07 2004-07-22 Procyte Corporation Stimulation of hair growth by compositions containing peptide copper complexes and minoxidil
US20050244509A1 (en) 2004-03-17 2005-11-03 Fu-Pao Tsao Ophthalmic solutions
JP2008528595A (ja) * 2005-01-28 2008-07-31 ザ プロクター アンド ギャンブル カンパニー 液体溶媒中における分散粒子としてのジヨードメチル−ｐ−トリルスルホン
GB0617024D0 (en) 2006-08-30 2006-10-11 Unilever Plc Hair treatment compositions incorporating hair substantive polymers
KR20080038710A (ko) 2006-10-31 2008-05-07 일양약품주식회사 미녹시딜과 트레티노인을 함유한 외용 에멀젼 발모용조성물
US7704533B2 (en) 2006-12-13 2010-04-27 J&J Consumer Companies, Inc. Compositions and methods of inducing hair growth utilizing Continus coggygria
US8623344B2 (en) 2007-06-29 2014-01-07 Mcneil-Ppc, Inc. Structured depilatory compositions
WO2009026473A2 (en) * 2007-08-21 2009-02-26 Hollis-Eden Pharmaceuticals, Inc. Stabilized therapeutic compositions and formulations
US8354099B2 (en) 2008-10-07 2013-01-15 Ahava-Dead Sea Laboratories Ltd. Skin-care compositions and uses thereof
FR2944435B1 (fr) 2009-04-17 2011-05-27 Sederma Sa Composition cosmetique comprenant de l'oridonine
US8470833B2 (en) 2009-12-15 2013-06-25 Mcneil-Ppc, Inc. Hair growth and/or regrowth compositions
US20130149271A1 (en) 2010-09-02 2013-06-13 Kelly Van Gogh Compositions for repairing and restoring keratin-containing fibers
RU2015106686A (ru) 2012-07-27 2016-09-20 Тайсо Фармасьютикал Ко., Лтд. Композиция для средства для наружного применения
AU2013227981B2 (en) 2012-09-10 2017-09-14 Ad Lunam Labs Inc. Excipient system for topical delivery of pharmaceutical agents
CA2936812C (en) 2014-01-06 2023-03-14 Ineos Europe Ag Polymer composition for caps and closures
US9675537B2 (en) * 2014-06-30 2017-06-13 Johnson & Johnson Consumer Inc. Hair growth composition and method
US10561593B2 (en) * 2015-12-28 2020-02-18 Johnson & Johnson Consumer Inc. Hair growth composition and method

Also Published As

Publication number Publication date
CN108472513B (zh) 2022-09-06
WO2017116937A1 (en) 2017-07-06
MX2018008012A (es) 2019-03-28
EP3397349A1 (en) 2018-11-07
RU2018122949A3 (enExample) 2020-04-17
CA3006576A1 (en) 2017-07-06
RU2018127471A (ru) 2020-01-31
US20170181950A1 (en) 2017-06-29
EP3397350A1 (en) 2018-11-07
IL259697B (en) 2021-05-31
KR20180097741A (ko) 2018-08-31
JP2019505576A (ja) 2019-02-28
TW201733589A (zh) 2017-10-01
AU2022279519A1 (en) 2023-02-02
BR112018013192A2 (pt) 2018-12-11
US10925824B2 (en) 2021-02-23
BR112018013104A2 (pt) 2018-12-11
MX387098B (es) 2025-03-19
JP2019501219A (ja) 2019-01-17
US11039996B2 (en) 2021-06-22
ZA201805065B (en) 2020-05-27
CN108472512A (zh) 2018-08-31
CA3006578C (en) 2023-10-10
KR102710869B1 (ko) 2024-09-30
TWI730023B (zh) 2021-06-11
TW201731512A (zh) 2017-09-16
RU2018126629A3 (enExample) 2020-04-23
ZA201805064B (en) 2020-05-27
JP7439020B2 (ja) 2024-02-27
BR112018013104B8 (pt) 2022-07-26
CN108472511A (zh) 2018-08-31
AU2022279519B2 (en) 2024-11-28
CA3006578A1 (en) 2017-07-06
IL259700B (en) 2020-11-30
US11185487B2 (en) 2021-11-30
KR20180095702A (ko) 2018-08-27
WO2017116940A1 (en) 2017-07-06
MX2018008010A (es) 2019-03-28
MX386927B (es) 2025-03-19
RU2018126629A (ru) 2020-01-30
MX2018008011A (es) 2019-03-28
AU2016381081A1 (en) 2018-06-07
US11666520B2 (en) 2023-06-06
AU2022279507A1 (en) 2023-02-02
IL259700A (en) 2018-07-31
MX382837B (es) 2025-03-13
JP2021138764A (ja) 2021-09-16
RU2764115C2 (ru) 2022-01-13
ES2878189T3 (es) 2021-11-18
BR112018013104B1 (pt) 2021-11-23
CA3006576C (en) 2024-02-13
JP7374957B2 (ja) 2023-11-07
JP2019505577A (ja) 2019-02-28
MX2021006697A (es) 2022-03-24
BR112018013174A2 (pt) 2018-12-11
JP7341663B2 (ja) 2023-09-11
BR112018013192B1 (pt) 2021-12-21
US20170181948A1 (en) 2017-06-29
TWI797070B (zh) 2023-04-01
US20200108004A1 (en) 2020-04-09
WO2017116938A1 (en) 2017-07-06
ZA201803518B (en) 2025-02-26
CA3006581C (en) 2023-08-08
CN108472511B (zh) 2023-07-07
JP2021152065A (ja) 2021-09-30
CN108472513A (zh) 2018-08-31
JP7430666B2 (ja) 2024-02-13
KR102735834B1 (ko) 2024-12-02
CA3006581A1 (en) 2017-07-06
US20200397682A1 (en) 2020-12-24
BR112018013192B8 (pt) 2022-07-26
KR102795824B1 (ko) 2025-04-17
CN108472512B (zh) 2022-11-15
AU2022279530A1 (en) 2023-02-02
JP7430487B2 (ja) 2024-02-13
KR20180095701A (ko) 2018-08-27
RU2018122949A (ru) 2020-01-30
IL259696A (en) 2018-07-31
EP3397348B1 (en) 2021-05-19
IL259697A (en) 2018-07-31
US20170181949A1 (en) 2017-06-29
US10561593B2 (en) 2020-02-18
JP2021152066A (ja) 2021-09-30
BR112018013174B1 (pt) 2021-11-23
AU2016381084A1 (en) 2018-06-07
RU2018127471A3 (enExample) 2020-04-06
TW201733588A (zh) 2017-10-01
AU2016381082A1 (en) 2018-06-07
JP7341664B2 (ja) 2023-09-11
TWI797071B (zh) 2023-04-01
EP3397348A1 (en) 2018-11-07
BR112018013174B8 (pt) 2022-07-26

Similar Documents

Publication Publication Date Title
MX390903B (es) Composición y método para el crecimiento del cabello.
EA201990565A1 (ru) Кристаллический 19-нор c3,3-дизамещенный c21-n-пиразолил стероид
PH12018500457A1 (en) New phenoxymethyl derivatives
MX389802B (es) Composiciones enriquecidas estereoquimicamente para administracion de acidos nucleicos.
CU20170077A7 (es) Compuesto derivado de benzamida sustituida con 1,3-tiazol-2-ilo útil para el tratamiento de trastornos neurogénicos, composiciones y combinaciones que lo comprende
MX388682B (es) Compuestos agonistas de gpr119 y metodo para tratar enfermedades y afecciones mediado a traves de gpr119.
PH12017501413A1 (en) Substituted nucleoside derivatives useful as anticancer agents
EA201691590A1 (ru) Бензимидазол-2-амины в качестве ингибиторов midhi
MY210123A (en) Tlr7/8 antagonists and uses thereof
TN2017000467A1 (en) Amido-substituted cyclohexane derivatives
NZ739676A (en) Heteroaryl compounds as irak inhibitors and uses thereof
MX373247B (es) Nuevos derivados de octahidro-pirrolo[3,4-c]-pirrol y análogos del mismo como inhibidores de atotaxina.
MX382122B (es) Oxiesteroles y metodos de uso de los mismos.
EA201791058A1 (ru) Морфолин- и 1,4-оксазепан-амиды в качестве агонистов соматостатинового рецептора подтипа 4 (sstr4)
EA201791896A1 (ru) Дезацетокситубулизин н и его аналоги
MY192425A (en) Polymorphs
MY201832A (en) Sulfonamide compounds and use thereof
CO2018007663A2 (es) Compuestos indolinonas y su uso en el tratamiento de enfermedades fibróticas
MX2020006596A (es) Hidroxiisoxazolinas y derivados de estos.
BR112018006314A2 (pt) composto da fórmula, composição, uso de composto da fórmula, método de combate a fungos fitopatogênicos e semente revestida
NO20180002A1 (en) Aminobenzisoxazole compounds as agonists of A7-nicotinic acetylcholine receptors
PH12017501601A1 (en) Use of isolated fractions of mastic gum for treating optic neuropathy
MX386902B (es) Metodos para el tratamiento de trastornos cardiovasculares.
EA201992844A1 (ru) Новые пероральные составы на основе белиностата
PH12017501147A1 (en) Total synthesis of trioxacarcin dc-45-a2 and preparation of trioxacarcin analogs